1Kawai N,Keep RF,Betz AL.Hyperglycemia and the vascular effects of cerebral ischemia[].Stroke.1997
2Kwiatkowski TG,Libman RB,Frankel M,et al.Effects of tissue plasminogen activator for acute ischemic stroke at one year.national institute of neurological disorders and stroke recombinant tissue plasminogen activator stroke study group[].The New England Journal of Medicine.1999
3Chamorro A,Vila N,Ascaso C,Elices E,et al.Blood pressure and functional recovery in acute ischemic stroke[].Stroke.1998
4Demchuk AM,Morgenstern LB,Krieger DW,et al.Serum glucose level and diabetes predict tissue plasminogen activatorrelated intracerebral hemorrhage in acute ischemic stroke[].Stroke.1999
5O’Connor RE,McGraw P,Edelsohn L.Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment[].Annals of Emergency Medicine.1999
6Manelfe C,Larrue V,von Kummer R,et al.Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator[].Stroke.1999
7Buttner T,Hellwig K,Muller T,et al.Intravenously administerd acetylsalicylic acid in combination with low-dose heparin in acute ischemic strode: a safetyanalysis[].Clinical Neuropharmacology.1998
8Bedner MM,Gross CE.Antiplatelet therapy in acute cerebral ischemia[].Stroke.1999
9Wahlgren NG,Ranasinha KW,Rosolassi T,et al.Clomethiazole acute stroke study ( class ): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients[].Stroke.1999
10Pantano P,Caramia F,Bozzao L,et al.Delayed increase in infarct volume after cerebral ischemia: correlation with thrombolytic treatment and clinical outcome[].Stroke.1999
